Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Droxidopa (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- 25 Oct 2019 Planned primary completion date changed from 1 Nov 2019 to 1 Dec 2019.
- 21 Aug 2018 Planned primary completion date changed from 1 Sep 2019 to 1 Nov 2019.
- 21 Aug 2018 Status changed from not yet recruiting to recruiting.